Treatment of HCV infection with pegylated interferons Graham R. FosterAbid R. Suddle OriginalPaper Pages: 49 - 55
Management of hematologic side effects: Impact on compliance and efficacy Furqaan AhmedIra M. Jacobson OriginalPaper Pages: 56 - 60
Antifibrotic targets and therapy in HCV Efsevia AlbanisScott L. Friedman OriginalPaper Pages: 61 - 67
Antiviral therapy in the HCV-coinfected patient with HIV and/or HBV James S. ParkNeeraj SarafDouglas T. Dieterich OriginalPaper Pages: 68 - 74
Antiviral therapy in the liver transplant candidate and recipient Gregory T. Everson OriginalPaper Pages: 75 - 82
